{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:59:52Z","timestamp":1794808792286,"version":"4.9.1"},"reference-count":60,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 108-2320-B-002-025"],"award-info":[{"award-number":["MOST 108-2320-B-002-025"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death worldwide. Chronic liver inflammation due to hepatitis virus infection and other major effectors is a major risk factor of HCC. Indoleamine 2,3-dioxygenase 1 (IDO1), a heme enzyme highly expressed upon stimulation with proinflammatory cytokines such as interferon-\u03b3 (IFN-\u03b3), is activated to modulate the tumor microenvironment and potentially crucial in the development of certain cancer types. Earlier studies have majorly reported an immunomodulatory function of IDO1. However, the specific role of IDO1 in cancer cells, particularly HCC, remains to be clarified. Analysis of The Cancer Genome Atlas Liver Hepatocellular Carcinoma (TCGA LIHC) dataset in the current study revealed a significant correlation between IDO1 expression and HCC. We further established inducible IDO1-expressing cell models by coupling lentivirus-mediated knockdown and IFN-\u03b3 induction of IDO1 in normal and HCC cells. In functional assays, proliferation and motility-related functions of HCC cells were compromised upon suppression of IDO1, which may partially be rescued by its enzymatic product, kynurenine (KYN), while normal hepatocytes were not affected. Aryl hydrocarbon receptor (AhR), a reported endogenous KYN receptor, is suggested to participate in tumorigenesis. In mechanistic studies, IDO1 activation promoted both AhR and \u03b2-catenin activity and nuclear translocation. Immunofluorescence staining and co-immunoprecipitation assays further disclosed interactions between AhR and \u03b2-catenin. In addition, we identified a Src-PTEN-PI3K\/Akt-GSK-3\u03b2 axis involved in \u03b2-catenin stabilization and activation following IDO1-mediated AhR activation. IDO1-induced AhR and \u03b2-catenin modulated the expression of proliferation- and EMT-related genes to facilitate growth and metastasis of HCC cells. Our collective findings provide a mechanistic basis for the design of more efficacious IDO1-targeted therapy for HCC.<\/jats:p>","DOI":"10.3390\/ijms222111661","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T23:51:36Z","timestamp":1635465096000},"page":"11661","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Aberrant Upregulation of Indoleamine 2,3-Dioxygenase 1 Promotes Proliferation and Metastasis of Hepatocellular Carcinoma Cells via Coordinated Activation of AhR and \u03b2-Catenin Signaling"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0660-7340","authenticated-orcid":false,"given":"Chih-Ta","family":"Chen","sequence":"first","affiliation":[{"name":"Graduate Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, No. 1, Jen-Ai Rd, Taipei 100, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hua","family":"Wu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, No. 1, Jen-Ai Rd, Taipei 100, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chi","family":"Hu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, No. 1, Jen-Ai Rd, Taipei 100, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Ching","family":"Nien","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, National Taiwan University Hospital, Taipei 100, Taiwan"},{"name":"Liver Disease Prevention and Treatment Research Foundation, Taipei 100, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Town","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Microbiology, College of Medicine, National Taiwan University, Taipei 100, Taiwan"},{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei 100, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Chuan","family":"Sheu","sequence":"additional","affiliation":[{"name":"Liver Disease Prevention and Treatment Research Foundation, Taipei 100, Taiwan"},{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei 100, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4420-211X","authenticated-orcid":false,"given":"Lu-Ping","family":"Chow","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, No. 1, Jen-Ai Rd, Taipei 100, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: Trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular Carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1717002","article-title":"Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma","volume":"379","author":"Meyer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Jemal, A., Ward, E.M., Johnson, C.J., Cronin, K.A., Ma, J.M., Ryerson, A.B., Mariotto, A., Lake, A.J., Wilson, R., and Sherman, R.L. (2017). Annual Report to the Nation on the Status of Cancer, 1975\u20132014, Featuring Survival. JNCI J. Natl. Cancer Inst., 109.","DOI":"10.1093\/jnci\/djx030"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2008.09.014","article-title":"Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease","volume":"136","author":"Lok","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/jnci\/djp288","article-title":"Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study","volume":"101","author":"Chang","year":"2009","journal-title":"Jnci-J. Natl. Cancer Inst."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-induced hepatocellular carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_9","first-page":"187","article-title":"The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect","volume":"155","author":"Marotta","year":"2004","journal-title":"Clin. Ter."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1200\/JCO.2004.10.041","article-title":"Tolerance and cancer: Mechanisms of tumor evasion and strategies for breaking tolerance","volume":"22","author":"Mapara","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Nagano, J., Shimizu, M., Hara, T., Shirakami, Y., Kochi, T., Nakamura, N., Ohtaki, H., Ito, H., Tanaka, T., and Tsurumi, H. (2013). Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073404"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.4049\/jimmunol.0904173","article-title":"Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model","volume":"185","author":"Ito","year":"2010","journal-title":"J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"IDO expression by dendritic cells: Tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1158\/1078-0432.CCR-11-1331","article-title":"Indoleamine 2,3-dioxygenase expression in human cancers: Clinical and immunologic perspectives","volume":"17","author":"Hanafi","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbrc.2005.09.032","article-title":"Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism","volume":"338","author":"Takikawa","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.ejca.2011.09.007","article-title":"Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients","volume":"48","author":"Speeckaert","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"73693","DOI":"10.18632\/oncotarget.17793","article-title":"Mesenchymal stem cells in inflammatory microenvironment potently promote metastatic growth of cholangiocarcinoma via activating Akt\/NF-kappaB signaling by paracrine CCL5","volume":"8","author":"Zhong","year":"2017","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nm1196","article-title":"Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy","volume":"11","author":"Muller","year":"2005","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/0008-5472.CAN-06-2925","article-title":"Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses","volume":"67","author":"Hou","year":"2007","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00432-008-0395-1","article-title":"Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma","volume":"134","author":"Pan","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2013.05.002","article-title":"IDO1 metabolites activate beta-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice","volume":"145","author":"Thaker","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/toxsci\/kfr080","article-title":"Coordinate regulation of cytochrome P450 1a1 expression in mouse liver by the aryl hydrocarbon receptor and the beta-catenin pathway","volume":"122","author":"Braeuning","year":"2011","journal-title":"Toxicol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-016-0570-y","article-title":"Aryl hydrocarbon receptor\/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and beta-Catenin and Akt activation","volume":"16","author":"Alhoshani","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.7150\/jca.18744","article-title":"GSK-3beta suppresses HCC cell dissociation in vitro by upregulating epithelial junction proteins and inhibiting Wnt\/beta-catenin signaling pathway","volume":"8","author":"Zhang","year":"2017","journal-title":"J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"40057","DOI":"10.1074\/jbc.M303621200","article-title":"Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase\/AKT cascades","volume":"278","author":"Lu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"G1006","DOI":"10.1152\/ajpgi.00427.2011","article-title":"Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation","volume":"302","author":"Xie","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"33972","DOI":"10.18632\/oncotarget.15687","article-title":"The regulation of beta-catenin activity and function in cancer: Therapeutic opportunities","volume":"8","author":"Shang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.18632\/oncotarget.2307","article-title":"The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination","volume":"5","author":"Lai","year":"2014","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35000034","article-title":"The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells","volume":"2","author":"Batlle","year":"2000","journal-title":"Nat. Cell. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1749-6632.2009.03704.x","article-title":"Inflammation and liver cancer: New molecular links","volume":"1155","author":"Berasain","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_35","unstructured":"WHO (1994). Hepatitis Viruses. International Agency for Research on Cancer (IARC), World Health Organization."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fimmu.2018.00151","article-title":"The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy","volume":"9","author":"Hornyak","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3748\/wjg.v23.i13.2286","article-title":"Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma","volume":"23","author":"Asghar","year":"2017","journal-title":"World J. Gastroentero"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1111\/cas.13811","article-title":"Mechanism and prognostic value of indoleamine 2,3-dioxygenase 1 expressed in hepatocellular carcinoma","volume":"109","author":"Li","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Shibata, Y., Hara, T., Nagano, J., Nakamura, N., Ohno, T., Ninomiya, S., Masahito, S., Tanaka, T., Saito, K., and Seishima, M. (2016). The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146279"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000492849","article-title":"The Clinicopathological and Prognostic Significance of IDO1 Expression in Human Solid Tumors: Evidence from a Systematic Review and Meta-Analysis","volume":"49","author":"Yu","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1777625","DOI":"10.1080\/2162402X.2020.1777625","article-title":"Trial watch: IDO inhibitors in cancer therapy","volume":"9","author":"Galluzzi","year":"2020","journal-title":"Oncoimmunology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1158\/0008-5472.CAN-18-0668","article-title":"IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis","volume":"79","author":"Bishnupuri","year":"2019","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-12-0014","article-title":"IDO is a nodal pathogenic driver of lung cancer and metastasis development","volume":"2","author":"Smith","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.toxlet.2008.01.003","article-title":"Hexachlorobenzene triggers AhR translocation to the nucleus, c-Src activation and EGFR transactivation in rat liver","volume":"177","author":"Randi","year":"2008","journal-title":"Toxicol. Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccr.2004.06.022","article-title":"PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients","volume":"6","author":"Nagata","year":"2004","journal-title":"Cancer Cell."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/cancers3010994","article-title":"Role of p53 in Cell Death and Human Cancers","volume":"3","author":"Ozaki","year":"2011","journal-title":"Cancers"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc2347","article-title":"The Cdk inhibitor p27 in human cancer: Prognostic potential and relevance to anticancer therapy","volume":"8","author":"Chu","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/carcin\/bgh289","article-title":"TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents","volume":"26","author":"Paajarvi","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/s41418-018-0160-1","article-title":"The AHR represses nucleotide excision repair and apoptosis and contributes to UV-induced skin carcinogenesis","volume":"25","author":"Pollet","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"11342","DOI":"10.1074\/jbc.RA119.008882","article-title":"The aryl hydrocarbon receptor is a tumor suppressor-like gene in glioblastoma","volume":"294","author":"Jin","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10555-008-9179-y","article-title":"E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer","volume":"28","author":"Schmalhofer","year":"2009","journal-title":"Cancer Metastasis Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s13058-014-0410-1","article-title":"Cancer\/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression","volume":"16","author":"Chen","year":"2014","journal-title":"Breast Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jare.2018.11.006","article-title":"Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a\/b-beta-catenin signalling, the stem cell phenotype and disease progression","volume":"16","author":"Mohamed","year":"2019","journal-title":"J. Adv. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"39209","DOI":"10.1074\/jbc.M206400200","article-title":"Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression","volume":"277","author":"Guaita","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.18632\/oncotarget.7438","article-title":"Tumoral indoleamine 2, 3-dioxygenase 1 is regulated by monocytes and T lymphocytes collaboration in hepatocellular carcinoma","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1158\/1078-0432.CCR-14-0122","article-title":"Intratumor heterogeneity in hepatocellular carcinoma","volume":"21","author":"Friemel","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000367754","article-title":"Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges","volume":"5","author":"Lu","year":"2016","journal-title":"Liver Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s12276-020-0404-2","article-title":"Quantitative phosphoproteomic analysis identifies the potential therapeutic target EphA2 for overcoming sorafenib resistance in hepatocellular carcinoma cells","volume":"52","author":"Chen","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1530\/ERC-16-0041","article-title":"AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells","volume":"23","author":"Lecoq","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nprot.2006.27","article-title":"Protocol for the fast chromatin immunoprecipitation (ChIP) method","volume":"1","author":"Nelson","year":"2006","journal-title":"Nat. Protoc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/21\/11661\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:21:57Z","timestamp":1760167317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/21\/11661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":60,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijms222111661"],"URL":"https:\/\/doi.org\/10.3390\/ijms222111661","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]}}}